Production (Stage)
BioAge Labs, Inc.
BIOA
$3.98
$0.030.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 19.18% | -- | -- | -- | -- |
| Gross Profit | -3.62% | -- | -- | -- | -- |
| SG&A Expenses | 94.39% | 74.64% | 41.01% | 14.84% | 0.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.68% | 86.54% | 150.33% | 13.85% | 11.37% |
| Operating Income | -28.35% | -86.54% | -150.33% | -13.85% | -11.37% |
| Income Before Tax | 0.49% | -0.82% | -60.05% | 20.98% | -17.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.49% | -0.82% | -60.05% | 20.98% | -17.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.49% | -0.82% | -60.05% | 20.98% | -17.21% |
| EBIT | -28.35% | -86.54% | -150.33% | -13.85% | -11.37% |
| EBITDA | -28.40% | -86.76% | -151.16% | -13.82% | -11.40% |
| EPS Basic | 95.36% | 95.32% | 23.39% | 22.75% | -17.16% |
| Normalized Basic EPS | 95.26% | 90.94% | 23.39% | 22.75% | -14.91% |
| EPS Diluted | 95.36% | 95.32% | 23.39% | 22.75% | -17.16% |
| Normalized Diluted EPS | 95.26% | 90.94% | 23.39% | 22.75% | -14.91% |
| Average Basic Shares Outstanding | 2,042.22% | 2,052.53% | 108.92% | 2.29% | 0.05% |
| Average Diluted Shares Outstanding | 2,042.22% | 2,052.53% | 108.92% | 2.29% | 0.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |